A meta-analysis of prospective and retrospective studies showed a positive association between IGF1 and the risk of prostate cancer but no significant association between IGF2, IGFBP1, IGFBP2, or IGFBP3 and the risk of prostate cancer [94]. This evidence concerns the gene IGFBP1 and prostate carcinoma.